147 related articles for article (PubMed ID: 33095913)
1. Pathfinders in oncology from the first clinical use of single-agent chemotherapy to the introduction of mammography.
Hajdu SI
Cancer; 2021 Jan; 127(1):12-26. PubMed ID: 33095913
[TBL] [Abstract][Full Text] [Related]
2. Pathfinders in oncology from the beginning of modern surgery of intracranial tumors to the introduction of the Pap smear.
Hajdu SI
Cancer; 2020 Jun; 126(12):2734-2749. PubMed ID: 32196649
[TBL] [Abstract][Full Text] [Related]
3. Pathfinders in oncology from the time the causal relation between tobacco use and lung cancer was established to publication of the first Cancer Staging Manual by the American Joint Committee on Cancer.
Hajdu SI
Cancer; 2021 Aug; 127(16):2828-2854. PubMed ID: 33970484
[TBL] [Abstract][Full Text] [Related]
4. Pathfinders in oncology from the end of the 19th century to the first description of Ewing sarcoma.
Hajdu SI
Cancer; 2019 Jul; 125(14):2345-2358. PubMed ID: 30985918
[TBL] [Abstract][Full Text] [Related]
5. A note from history: Landmarks in history of cancer, Part 6.
Hajdu SI; Vadmal M
Cancer; 2013 Dec; 119(23):4058-82. PubMed ID: 24105604
[TBL] [Abstract][Full Text] [Related]
6. Pathfinders in oncology from the beginning of the 19th century to the inauguration of the first cancer hospital in the United States.
Hajdu SI
Cancer; 2018 Jan; 124(2):230-241. PubMed ID: 29149477
[TBL] [Abstract][Full Text] [Related]
7. A note from history: Landmarks in history of cancer, part 7.
Hajdu SI; Vadmal M; Tang P
Cancer; 2015 Aug; 121(15):2480-513. PubMed ID: 25873516
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.
Kris MG; Gaspar LE; Chaft JE; Kennedy EB; Azzoli CG; Ellis PM; Lin SH; Pass HI; Seth R; Shepherd FA; Spigel DR; Strawn JR; Ung YC; Weyant M
J Clin Oncol; 2017 Sep; 35(25):2960-2974. PubMed ID: 28437162
[TBL] [Abstract][Full Text] [Related]
9. Arthur Purdy Stout (1885-1967), a pioneer of surgical pathology: a survey of his Notes on the Education of an "Oncological" Surgical Pathologist.
Azar HA
Ann Diagn Pathol; 1998 Aug; 2(4):271-9. PubMed ID: 9845748
[TBL] [Abstract][Full Text] [Related]
10. Gestational carcinoma of the female breast.
Wallack MK; Wolf JA; Bedwinek J; Denes AE; Glasgow G; Kumar B; Meyer JS; Rigg LA; Wilson-Krechel S
Curr Probl Cancer; 1983 Mar; 7(9):1-58. PubMed ID: 6303698
[TBL] [Abstract][Full Text] [Related]
11. Pathfinders in oncology from the end of the Middle Ages to the beginning of the 19th century.
Hajdu SI
Cancer; 2017 Jun; 123(11):1888-1897. PubMed ID: 28140461
[TBL] [Abstract][Full Text] [Related]
12. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
[TBL] [Abstract][Full Text] [Related]
13. Improving the cancer chemotherapy use process.
Fischer DS; Alfano S; Knobf MT; Donovan C; Beaulieu N
J Clin Oncol; 1996 Dec; 14(12):3148-55. PubMed ID: 8955661
[TBL] [Abstract][Full Text] [Related]
14. Non-surgical management of early breast cancer in the United Kingdom: follow-up. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology.
Maher EJ
Clin Oncol (R Coll Radiol); 1995; 7(4):227-31. PubMed ID: 8845317
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
16. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
17. Factors delaying chemotherapy for breast cancer in four urban and rural oncology units.
Fox PN; Chatfield MD; Beith JM; Allison S; Della-Fiorentina S; Fisher D; Turley K; Grimison PS
ANZ J Surg; 2013 Jul; 83(7-8):533-8. PubMed ID: 22984845
[TBL] [Abstract][Full Text] [Related]
18. 3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET.
Nakamura S; Kenjo H; Nishio T; Kazama T; Do O; Suzuki K
Breast Cancer; 2001; 8(4):351-4. PubMed ID: 11791129
[TBL] [Abstract][Full Text] [Related]
19. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.
Moran MS; Schnitt SJ; Giuliano AE; Harris JR; Khan SA; Horton J; Klimberg S; Chavez-MacGregor M; Freedman G; Houssami N; Johnson PL; Morrow M
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):553-64. PubMed ID: 24521674
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
